Avis de non-consommation d’eau aux campus de Sherbrooke jusqu'à dimanche soir
Mise à jour à 14h45, le 21 septembre -La Ville de Sherbrooke a informé la population que les dernières analyses de l'eau de Sherbrooke n'indiquent pas la présence de la bactérie E.Coli dans ses réserves ...
Our mission is based on a very simple definition of pharmacology: the study of the mechanisms of interaction between an active agent and its target cell. At the Institute, pharmacology incorporates concepts and data from disciplines such as physiology; biochemistry; molecular biology; medicinal, structural, and synthetic chemistry, and applies them to the validation of new targets, the discovery of molecular diagnostic tools, as well as to the optimization of enabling technologies.
The Institute’s fundamental focus is:
- The discovery of new molecular and cellular mechanisms key to the development of human pathologies;
- The discovery of new bioactive molecules with the diagnostic or therapeutic potential to tackle these mechanisms.
- The development of technologies that promote drug discovery diagnostic agents.
The medical fields covered by the Institute's applications include, but are not limited to, cardiovascular diseases, respiratory diseases, inflammatory diseases, cancer, infectious diseases, and pain.
Support for translational research
The Institute supports and promotes the development of business opportunities for research products created at the Université de Sherbrooke and the creation of companies, in association with its Research, Innovation and Creation Support Services (SARIC), TransferTech (formerly SOCPRA), and the Office of the Vice-President, Research, Partnerships and Entrepreneurship.
With its interdisciplinary and product-oriented research philosophy, the Institute has become a leading partner for companies in the pharmaceutical and biotechnology industry.